New results of a sub-study carried out as part of a worldwide breast cancer prevention study (IBIS-II) show that after two years of taking the aromatase inhibitor, anastrozole, postmenopausal women at ...

The Queen Mary University of London professor leading an international breast cancer study says anastrozole - rather than tamoxifen - should be the preventive drug-of-choice for post-menopausal women ...

The Queen Mary University of London professor leading an international breast cancer study says anastrozole - rather than tamoxifen - should be the preventive drug-of-choice for post-menopausal women ...

Share on Pinterest Anastrozole can reduce breast cancer risk after menopause, but does it come with its own risks? Image credit: shironosov/Getty Images. A drug used as a breast cancer treatment has ...

DEAR DR. ROACH: I am 78 years old. Breast cancer runs in my family, and I am one of the lucky ones who had a lump that was caught early through an annual mammogram. I had a partial mastectomy, which ...

June 6, 2007 (Chicago) — One of the worst adverse effects of treatment with aromatase inhibitors in breast cancer — drug-induced bone loss of around 2% each year — can be prevented by the use of a ...

The news that the U.K. has approved a preventive drug for post-menopausal women at risk of developing breast cancer wasn’t a shock to breast medical oncologist Abenaa Brewster. But the fact that a ...

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYS: AZN) today launched new digital resources to educate patients on how to enroll in ARIMIDEX Direct. Resources include a "how to" video outlining ...

AstraZeneca announces first direct-to-patient program offering the brand ARIMIDEX® (anastrozole) Tablets to patients for only $40 per month Patients with a valid prescription would get the medication ...

American Association for Cancer Research. "No significant differences in recurrence rates among women with DCIS taking anastrozole or tamoxifen." ScienceDaily. ScienceDaily, 13 December 2015.